Gene · 407039
Papers2,468
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,468
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials. | Pharmaceutics | 2022 | 35456698 | PubTator, text mining | PubMed |
| Impact of microRNA Regulated Macrophage Actions on Adipose Tissue Function in Obesity. | Cells | 2022 | 35456015 | PubTator, text mining | PubMed |
| Epigenetics in Precision Nutrition. | J Pers Med | 2022 | 35455649 | PubTator, text mining | PubMed |
| Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives. | Pharmaceuticals (Basel) | 2022 | 35455438 | PubTator, text mining | PubMed |
| Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. | Front Pharmacol | 2022 | 35444536 | PubTator, text mining | PubMed |
| Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors. | Nat Commun | 2022 | 35440108 | PubTator, text mining | PubMed |
| Loss of RNA binding protein HuD facilitates the production of the senescence-associated secretory phenotype. | Cell Death Dis | 2022 | 35411051 | PubTator, text mining | PubMed |
| FAM201A, a long noncoding RNA potentially associated with atrial fibrillation identified by ceRNA network analyses and WGCNA. | BMC Med Genomics | 2022 | 35410298 | PubTator, text mining | PubMed |
| Profiling Blood Serum Extracellular Vesicles in Plaque Psoriasis and Psoriatic Arthritis Patients Reveals Potential Disease Biomarkers. | Int J Mol Sci | 2022 | 35409365 | PubTator, text mining | PubMed |
| First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers. | Int J Mol Sci | 2022 | 35409311 | PubTator, text mining | PubMed |
| CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies. | Mol Ther Nucleic Acids | 2022 | 35402077 | PubTator, text mining | PubMed |
| MicroRNA loaded edible nanoparticles: an emerging personalized therapeutic approach for the treatment of obesity and metabolic disorders. | Theranostics | 2022 | 35401814 | PubTator, text mining | PubMed |
| MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis. | Front Immunol | 2022 | 35401568 | PubTator, text mining | PubMed |
| Natural Flavonoids Derived From Fruits Are Potential Agents Against Atherosclerosis. | Front Nutr | 2022 | 35399657 | PubTator, text mining | PubMed |
| Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review. | Breast Cancer Res Treat | 2022 | 35397079 | PubTator, text mining | PubMed |
| COVID-19, Anti-NMDA Receptor Encephalitis and MicroRNA. | Front Immunol | 2022 | 35392089 | PubTator, text mining | PubMed |
| circ_0000567/miR-421/TMEM100 Axis Promotes the Migration and Invasion of Lung Adenocarcinoma and Is Associated with Prognosis. | J Cancer | 2022 | 35371319 | PubTator, text mining | PubMed |
| Is there a role for stem cell therapy in erectile dysfunction secondary to cavernous nerve injury? Network meta-analysis from animal studies and human trials. | Ther Adv Urol | 2022 | 35371295 | PubTator, text mining | PubMed |
| The Interplay Between Gut Microbiota and miRNAs in Cardiovascular Diseases. | Front Cardiovasc Med | 2022 | 35369298 | PubTator, text mining | PubMed |
| Functional role of the SLC7A11-AS1/xCT axis in the development of gastric cancer cisplatin-resistance by a GSH-dependent mechanism. | Free Radic Biol Med | 2022 | 35367340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407039/papers?page=28